首页> 美国卫生研究院文献>Marine Drugs >Structural Determinant and Its Underlying Molecular Mechanism of STPC2 Related to Anti-Angiogenic Activity
【2h】

Structural Determinant and Its Underlying Molecular Mechanism of STPC2 Related to Anti-Angiogenic Activity

机译:与抗血管生成活性相关的STPC2的结构决定因素及其潜在分子机理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, we aimed to use different strategies to further uncover the anti-angiogenic molecular mechanism of a fucoidan-like polysaccharide STPC2, isolated from brown alga Sargassum thunbergii. A desulfated derivative, STPC2-DeS, was successfully prepared and identified. The native polysaccharide and desulfated product were subjected to evaluate their anti-angiogenic effects. In the tube formation assay, STPC2 showed dose-dependent inhibition. In addition, STPC2 could distinctly inhibit the permeation of HUVEC cells into the lower chamber. Moreover, a significant reduction of microvessel density was observed in chick chorioallantoic membrane assay treated with STPC2. Meanwhile, STPC2 was found to repress the VEGF-induced neovessel formation in the matrigel plug assay in vivo. However, STPC2-DeS failed to suppress the anti-angiogenic activity via these in vitro and in vivo strategies. In addition, we demonstrated that STPC2 could significantly downregulate the phosphorylation of VEGFR2 and its related downstream Src family kinase, focal adhesion kinase, and AKT kinase. Furthermore, surface plasmon resonance assay revealed that STPC2 bound strongly to VEGF to interfere with VEGF–VEGFR2 interaction. Taken together, these results evidently demonstrated that STPC2 exhibited a potent anti-angiogenic activity through binding to VEGF via sulfated groups to impede VEGF–VEGFR2 interaction, thus affected the downstream signaling molecules.
机译:在这项研究中,我们旨在使用不同的策略来进一步揭示从褐藻类海藻Sargassum thunbergii分离出的岩藻依聚糖样多糖STPC2的抗血管生成分子机制。成功制备并鉴定了脱硫衍生物STPC2-DeS。对天然多糖和脱硫产物进行评估以评估它们的抗血管生成作用。在试管形成试验中,STPC2显示出剂量依赖性抑制作用。此外,STPC2可以明显抑制HUVEC细胞渗透到下腔室。此外,在用STPC2处理的鸡绒膜尿囊膜测定中观察到微血管密度显着降低。同时,在基质胶塞试验中发现STPC2可抑制VEGF诱导的新血管形成。但是,STPC2-DeS无法通过这些体外和体内策略抑制抗血管生成活性。此外,我们证明STPC2可以显着下调VEGFR2及其相关下游Src家族激酶,粘着斑激酶和AKT激酶的磷酸化。此外,表面等离振子共振测定表明,STPC2与VEGF牢固结合,从而干扰VEGF-VEGFR2的相互作用。综上所述,这些结果显然表明,STPC2通过硫酸化基团与VEGF结合而阻碍VEGF-VEGFR2的相互作用,从而显示出强大的抗血管生成活性,从而影响了下游信号分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号